RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Aspira Pathlab & Diagnostics Stock

Aspira Pathlab & Diagnostics Equity 2024

Aspira Pathlab & Diagnostics Equity

101.43 M INR

Ticker

540788.BO

ISIN

INE500C01017

In 2024, Aspira Pathlab & Diagnostics's equity was 101.43 M INR, a -20.69% increase from the 127.89 M INR equity in the previous year.

Aspira Pathlab & Diagnostics Aktienanalyse

What does Aspira Pathlab & Diagnostics do?

Aspira Pathlab & Diagnostics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Aspira Pathlab & Diagnostics's Equity

Aspira Pathlab & Diagnostics's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Aspira Pathlab & Diagnostics's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Aspira Pathlab & Diagnostics's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Aspira Pathlab & Diagnostics's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Aspira Pathlab & Diagnostics’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Aspira Pathlab & Diagnostics stock

What is the equity of Aspira Pathlab & Diagnostics this year?

Aspira Pathlab & Diagnostics has equity of 101.43 M INR this year.

What was the equity of Aspira Pathlab & Diagnostics compared to the previous year?

The equity of Aspira Pathlab & Diagnostics has increased/decreased by -20.69% decreased compared to the previous year.

What impact does a high equity have on investors of Aspira Pathlab & Diagnostics?

A high equity is advantageous for investors of Aspira Pathlab & Diagnostics as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Aspira Pathlab & Diagnostics?

A low equity can be a risk for investors of Aspira Pathlab & Diagnostics, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Aspira Pathlab & Diagnostics affect the company?

An increase in equity of Aspira Pathlab & Diagnostics can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Aspira Pathlab & Diagnostics affect the company?

A reduction in equity of Aspira Pathlab & Diagnostics can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Aspira Pathlab & Diagnostics?

Some factors that can affect the equity of Aspira Pathlab & Diagnostics include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Aspira Pathlab & Diagnostics so important for investors?

The equity of Aspira Pathlab & Diagnostics is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Aspira Pathlab & Diagnostics take to change the equity?

To change equity, Aspira Pathlab & Diagnostics can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Aspira Pathlab & Diagnostics pay?

Over the past 12 months, Aspira Pathlab & Diagnostics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aspira Pathlab & Diagnostics is expected to pay a dividend of 0 INR.

What is the dividend yield of Aspira Pathlab & Diagnostics?

The current dividend yield of Aspira Pathlab & Diagnostics is .

When does Aspira Pathlab & Diagnostics pay dividends?

Aspira Pathlab & Diagnostics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Aspira Pathlab & Diagnostics?

Aspira Pathlab & Diagnostics paid dividends every year for the past 0 years.

What is the dividend of Aspira Pathlab & Diagnostics?

For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Aspira Pathlab & Diagnostics located?

Aspira Pathlab & Diagnostics is assigned to the '-' sector.

Wann musste ich die Aktien von Aspira Pathlab & Diagnostics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Aspira Pathlab & Diagnostics from 9/26/2024 amounting to 0 INR, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did Aspira Pathlab & Diagnostics pay the last dividend?

The last dividend was paid out on 9/26/2024.

What was the dividend of Aspira Pathlab & Diagnostics in the year 2023?

In the year 2023, Aspira Pathlab & Diagnostics distributed 0 INR as dividends.

In which currency does Aspira Pathlab & Diagnostics pay out the dividend?

The dividends of Aspira Pathlab & Diagnostics are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Aspira Pathlab & Diagnostics

Our stock analysis for Aspira Pathlab & Diagnostics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aspira Pathlab & Diagnostics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.